Want to see ELMTY full AI Analyst Report?
Top Page
Elementis PLC Unsponsored ADR
(OTC:ELMTY)
Select Model
Select Model
Rating:60Neutral
Price Target:
$10.00
Action:N/A
Date:09/24/26
Overall score is driven primarily by stable-to-improving fundamentals at the operating level and consistently positive cash generation, but constrained by ongoing net losses and a declining revenue trend. Technicals are mildly supportive but not strong, and valuation is reasonable with a modest dividend yield.
Positive Factors
Strong Operating Margins
Strong gross and operating margins indicate that Elementis retains meaningful pricing, product-mix, or formulation advantages in specialty additives. If maintained, this profitability provides a durable base for funding innovation, serving customers, and absorbing fluctuations across cyclical end markets.
Negative Factors
Declining Revenue
The renewed revenue decline signals weakening demand, unfavorable volume, or mix pressure across Elementis’s end markets. Even with strong margins, a shrinking top line can reduce operating scale, constrain reinvestment, and make sustained profit improvement more difficult over the next several quarters.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong Operating Margins
Strong gross and operating margins indicate that Elementis retains meaningful pricing, product-mix, or formulation advantages in specialty additives. If maintained, this profitability provides a durable base for funding innovation, serving customers, and absorbing fluctuations across cyclical end markets.
Read all positive factors
Elementis PLC Unsponsored ADR (ELMTY) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$1.31B
Dividend Yield2.47%
Average Volume (3M)0.00
Price to Earnings (P/E)18.3
Beta (1Y)0.74
Revenue Growth-8.97%
EPS GrowthN/A
CountryUS
Employees989
SectorGeneral
Sector StrengthN/A
IndustryChemicals - Specialty
Share Statistics
EPS (TTM)0.52
Shares Outstanding141,369,140
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio5.73
Price to Book (P/B)1.88
Price to Sales (P/S)2.02
P/FCF Ratio22.84
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Elementis PLC Unsponsored ADR Business Overview & Revenue Model
Company Description
Elementis plc functions as a global producer of specialty chemicals, maintaining operations across the United Kingdom, North America, other European regions, and various international markets. Its business activities are structured into four key d...
How the Company Makes Money
Elementis makes money primarily by selling specialty chemical additives and formulated ingredients to business customers (B2B). Revenue is generated from (1) product sales into its key end markets—most notably coatings and personal care—where its ...
Elementis PLC Unsponsored ADR Earnings Call Summary
Earnings Call Date:Mar 05, 2026
(Q4-2025)
| Next Earnings Date:Mar 11, 2027
Earnings Call Sentiment Positive
The call emphasized strong profitability, margin expansion, strategic portfolio simplification, innovation momentum and meaningful cost-savings delivery, while acknowledging softer top-line trends in Coatings, working capital and cash-flow pressures and remaining operational fixes at St. Louis. Overall, management presented a confident, execution-focused outlook with clear medium-term targets (mid-single-digit revenue growth, >23% operating margin, >90% three-year cash conversion), supported by sustainability and safety progress and disciplined bolt-on M&A.Positive Updates
Strong Adjusted Operating Profit and Margin Expansion
Adjusted operating profit increased 4.6% year-on-year to $126.7 million, driving a 150 basis point improvement in group adjusted operating margin to 21.2%.
Negative Updates
Coatings Revenue and Profit Decline
Coatings revenue fell to $373.0 million from $386.4 million the prior year, impacted by weak industrial and decorative markets and one-off high-margin sales in 2024; adjusted operating profit declined to $70.4 million and margin declined to 18.9% from 20.3%.
Read all updates
Q4-2025 Updates
Positive
Negative
Strong Adjusted Operating Profit and Margin Expansion
Adjusted operating profit increased 4.6% year-on-year to $126.7 million, driving a 150 basis point improvement in group adjusted operating margin to 21.2%.
Read all positive updates
Company Guidance
The company’s guidance under the Elevate Elementis strategy targets mid‑single‑digit revenue growth, operating margins of >23%, 3‑year operating cash conversion >90% and ROCE (ex‑goodwill) >30%; for 2026 management flags CapEx of 4–5% of revenue, a small working‑capital outflow (no factoring), and expects to be circa 1x net debt/EBITDA organically by end‑2026 (after distributing net proceeds from the pharma sale to shareholders). For context, 2025 headlines (the base year) were revenue $597.5m (‑1.9% cc), adjusted operating profit $126.7m (margin 21.2%, +150bps), adjusted EPS $0.137 (+14.2%), free cash flow $41m and adjusted operating cash flow $104.7m, with net debt $185.4m (1.3x) after returning $79.1m to shareholders (buyback + dividends) and cancelling ~4% of share capital. Management also expects further self‑help savings (delivered $18m + $6m from the new program, $4m remaining to end‑2026), to raise R&D from 2% to 3% of revenue (50% increase), to push innovation sales toward a 20% target (16.4% in 2025), to improve service metrics (On‑Time‑In‑Full half‑way to a 20% uplift) and to continue operational improvements (St. Louis debottlenecking +20% since H1, ~2/3 of the 30% opportunity).Elementis PLC Unsponsored ADR Financial Statement Overview
Summary
Income Statement
56
Neutral
Balance Sheet
63
Positive
Cash Flow
61
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 606.65M | 598.90M | 738.30M | 713.40M | 736.40M | 709.40M |
| Gross Profit | 294.76M | 279.15M | 338.00M | 284.30M | 298.90M | 289.00M |
| EBITDA | 146.84M | 137.42M | 26.10M | 114.80M | 151.90M | 87.30M |
| Net Income | 74.02M | -45.61M | -47.80M | 26.50M | -51.10M | 2.50M |
Balance Sheet | ||||||
| Total Assets | 1.14B | 1.11B | 1.31B | 1.51B | 1.63B | 1.84B |
| Cash, Cash Equivalents and Short-Term Investments | 86.20M | 54.60M | 59.90M | 65.80M | 54.90M | 84.60M |
| Total Debt | 264.50M | 256.60M | 253.90M | 300.90M | 453.70M | 522.70M |
| Total Liabilities | 472.30M | 470.70M | 551.40M | 664.10M | 843.10M | 935.60M |
| Stockholders Equity | 662.70M | 643.90M | 757.00M | 847.30M | 783.90M | 901.00M |
Cash Flow | ||||||
| Free Cash Flow | 38.39M | 53.02M | 62.20M | 38.60M | 29.90M | 13.60M |
| Operating Cash Flow | 64.96M | 75.38M | 100.00M | 76.80M | 77.00M | 66.70M |
| Investing Cash Flow | -21.02M | -8.32M | -37.50M | 101.10M | -46.90M | -65.00M |
| Financing Cash Flow | -18.81M | -82.69M | -59.80M | -168.00M | -57.80M | -25.30M |
Elementis PLC Unsponsored ADR Technical Analysis
Positive
―
Price Trends
9.48
Positive
8.82
Positive
8.66
Positive
Market Momentum
-0.02
Negative
54.94
Neutral
66.42
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ELMTY, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 9.33, equal to the 50-day MA of 9.48, and equal to the 200-day MA of 8.66, indicating a bullish trend. The MACD of -0.02 indicates Negative momentum. The RSI at 54.94 is Neutral, neither overbought nor oversold. The STOCH value of 66.42 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for ELMTY.
Elementis PLC Unsponsored ADR Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | $2.38B | 19.41 | 9.15% | 1.88% | 2.87% | 534.76% | |
67 Neutral | $4.01B | 21.30 | 12.07% | 2.40% | -4.74% | -53.83% | |
62 Neutral | $1.41B | -519.83 | -0.22% | 2.53% | 7.63% | -104.57% | |
60 Neutral | $1.31B | 18.33 | 11.29% | 2.47% | -8.97% | ― | |
56 Neutral | $3.13B | 59.58 | 2.77% | 2.46% | -1.39% | ― | |
56 Neutral | $2.06B | -30.00 | -4.04% | 0.73% | 4.06% | -3189.89% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
* General Sector Average
ELMTY
Elementis PLC Unsponsored ADR
9.51
0.94
10.94%
ASH
Ashland
67.92
21.04
44.89%
CBT
Cabot
76.91
3.42
4.65%
IOSP
Innospec
95.32
19.42
25.58%
MTX
Minerals Technologies
65.40
3.84
6.23%
SCL
Stepan Company
62.38
16.12
34.84%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.